Article

New dry eye emulsion introduced

A new therapy (Retaine MGD, OCuSOFT) is available for those who have dry eye syndrome and meibomian gland dysfunction.

Rosenberg, TX-A new therapy (Retaine MGD, OCuSOFT) is available for those who have dry eye syndrome and meibomian gland dysfunction.

The company says it’s the only preservative-free oil-in-water emulsion that moisturizes, lubricates, and protects moderately to severely dry eyes. Using a proprietary cationic process (Novasorb) that binds positively charged ions to the negatively charged ocular surface, the product is designed to prolong corneal contact time to enhance comfort. The hypotonicity of the emulsion adds moisture by lowering the salt concentration of tears, and the lipid component is designed to lubricate and protect the surface of the eye.

“OCuSOFT is extremely excited to offer such a unique solution for dry eye therapy,” said Cynthia L. Barratt, president and chief executive officer of OCuSOFT. “We believe [the emulsion] will become the standard of care for those patients suffering from meibomian gland dysfunction as well as moderate to severe dry eyes.”

The emulsion is packaged in 30 single-dose vials. The company plans to expand the line to include additional artificial tear products.

Special discount pricing is available to physicians dispensing the emulsion from their offices, and patients also may order it directly online at www.retainebrand.com.

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
© 2025 MJH Life Sciences

All rights reserved.